Trial NCT03876028

View at ClinicalTrials.gov 
Org. Study IDs: CCTL019L12101C

Last trial update was posted on 2023-01-31

MeSH Interventions

Ibrutinib Tisagenlecleucel

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B-cell Lymphoma

Stopping Reasons

Business reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID